Community Early Detection of Chronic Obstructive Pulmonary Diseases using Quantitative LDCT Imaging and Machine Learning
In recent years, artificial intelligence (AI) has developed vigorously, and gradually affected the development of the medical industry, becoming an vital factor in enhancing the medical level. Due to the advantages of computed tomography (CT), such as high density resolution, non duplication of tissue structure images, and the possibilities of multiple imaging post, the quantitative analysis with CT imaging has shown broad application space and enormous potential in COPD early screening and diagnosis. With the widespread utilize of low-dose CT (LDCT) for lung cancer screening, and the opportunistic CT-COPD screening proposed by 2024 GOLD guidance, early detection for COPD patients using these scans can be implemented in community.
However, it cannot be overlooked that published programs are either predominantly based on datasets from Western smokers or focus on patients with moderate or severe COPD in China, who are significantly heterogeneous compared to undiagnosed patients in our communities. Thus, whether those approaches could be applied to distinct datasets extracted from real-world scenarios, especially among the Chinese population, remains largely unknown.
Our team, centered on the community population in Guangdong, Guangzhou, China, has verified the benefits of weakly labeled LDCT images for COPD detection using multimodal data of chest LDCT quantitative characteristics, questionnaires, and CT reports, and successfully constructed a robust machine learning model. We hope that this tool can be applied on a wider scale and specifically propose to use COPD and control LDCT images from NLST project for external validation.
1、With inspiratory chest LDCT quantitative parameters and questionnaire data, a robust COPD early screening model was constructed based on machine learning.
2、Conduct external validation through a multi-center cohort to demonstrate the extrapolation of the model.
3、Perform subgroup analysis on the validation datasets to define the scope of model application.
4、Develop an online app based on the model to facilitate quick early detection of COPD by doctors.
5、Publish one article on the Q1 journal.
Wenju Lu, State Key Laboratory of Respiratory Diseases, Guangdong Key Laboratory of Vascular Diseases, National Clinical Research Center for Respiratory Diseases, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
Zili Zhang, State Key Laboratory of Respiratory Diseases, Guangdong Key Laboratory of Vascular Diseases, National Clinical Research Center for Respiratory Diseases, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
Zhenyu Liang, National Clinical Research Center for Respiratory Diseases, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
Cuixia Liang, Neusoft Inc., Liaoning, Shenyang, China